COVID-19 and Inflammatory Bowel Disease

The COVID-19 pandemic caused by the SARS-CoV-2 virus represents an unprecedented global health crisis. Safe and effective vaccines were rapidly developed and deployed that reduced COVID-19-related severe disease, hospitalization, and death. Patients with inflammatory bowel disease (IBD) are not at increased risk of severe disease or death from COVID-19, and data from large cohorts of IBD patients demonstrate that COVID-19 vaccination is safe and effective. Ongoing research is clarifying the long-term impact of SARS-CoV-2 infection on IBD patients, long-term immune responses to COVID-19 vaccination, and optimal timing for repeated COVID-19 vaccination doses.

Source: Gastroenterology Clinics of North America - October 30, 2022 Category: Gastroenterology Authors: Keith C. Summa, Stephen B. Hanauer, Clifford Joseph Barborka Source Type: research